Northstrive Biosciences and Yuva Biosciences’ collaboration will leverage MitoNova™, YuvaBio’s proprietary mitochondrial science-focused artificial intelligence platform, to discover and ...

Collaborating with Yuva Biosciences and utilizing advanced AI technology, the analysis revealed insights into how EL-22 could potentially counteract muscle loss associated with GLP-1 receptor ...

NEWPORT BEACH, Calif. - Northstrive Biosciences Inc., a subsidiary of PMGC Holdings Inc. (NASDAQ:ELAB), a micro-cap biotech company currently valued at $2.82 million, has announced a partnership with ...

NEWPORT BEACH, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Northstrive Biosciences Inc. (“Northstrive” or “Northstrive Biosciences”), a subsidiary of PMGC ...

Northstrive Biosciences and Yuva Biosciences' collaboration will leverage MitoNova™, YuvaBio's proprietary mitochondrial science-focused artificial intelligence platform, to discover and develop novel ...